|
|
|
|
|
Detail |
| hsa-miR-205 |
|
Unspecified |
MicroRNA expression profiling in prostate cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. |
2006 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Real-time expression profiling of microRNA precursors in human cancer cell lines. |
2005 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Micro-RNA profiling in kidney and bladder cancers. |
2007 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. |
2007 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Causal |
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. |
2008 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
MicroRNA expression profiles of esophageal cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.
|
2008 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
A microRNA expression ratio defining the invasive phenotype in bladder tumors. |
2008 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Causal |
MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. |
2009 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. |
2009 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Causal |
microRNA-205 regulates HER3 in human breast cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-205 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|